- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03265353
Vascular Effects of Dietary Potassium
November 4, 2020 updated by: University of Delaware
Vascular Effects of Dietary Potassium in Humans
The purpose of this study is to determine if dietary potassium can attenuate the deleterious effects of high sodium on blood vessel function in healthy, salt-resistant participants.
Study Overview
Status
Completed
Conditions
Detailed Description
Cardiovascular disease remains a major Public Health problem in the U.S. and is the result of diseases such as atherosclerosis and high blood pressure (BP).
Several dietary factors have been implicated as risk factors including high sodium and low potassium diets.
Indeed, it is well known that excess sodium can increase BP while potassium rich diets have BP lowering properties.
While the role of these two nutrients on BP is widely accepted, their impact on the vasculature has received less attention.
Endothelial dysfunction, characterized by impaired dilation is an important non-traditional risk factor for atherosclerosis.
Data in animal models suggest that salt loading, independent of changes in BP, results in endothelial dysfunction while evidence is mounting that potassium may be beneficial to vascular health.
Further, potassium may be more effective in the presence of high sodium however the role of potassium in protecting the vasculature from a high sodium diet in salt-resistant adults has not been explored.
A potential mechanism responsible for sodium induced vascular dysfunction is overproduction of reactive oxygen species resulting in reduced nitric oxide (NO) production/ bioavailability.
It has been suggested that potassium can counteract sodium's effect by reducing ROS.
The central hypothesis is that potassium can protect against the deleterious effects of high sodium on the vasculature by reducing oxidative stress and preserving NO.
In this grant, the investigators propose to use a 21-day controlled feeding study to compare the effects of a high sodium diet (300 mmol) combined with either a high (120 mmol) or moderate (65 mmol) amount of potassium and low sodium (50 mmol) combined with moderate potassium (crossover design, diet order sequence randomized) on 2 levels of the vasculature, conduit artery and microvasculature.
These experiments will be performed in salt-resistant participants to study the vascular effects alone, independent of changes in BP.
Study Type
Interventional
Enrollment (Actual)
47
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19716
- University of Delaware
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy
- normal blood pressure
Exclusion Criteria:
- hypertension
- history of heart disease
- diabetes
- kidney disease
- obese (BMI ≥30)
- significant weight changes in the last 6 months
- use of tobacco products
- pregnant
- on a special diet (gluten free; vegan)
- take any medications for the above conditions
- endurance trained athletes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Moderate Potassium/Low Sodium Diet
Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the moderate potassium/low sodium diet.
|
7 days of the prescribed diet
|
|
Other: Moderate Potassium/High Sodium Diet
Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the moderate potassium/high sodium diet.
|
7 days of the prescribed diet
|
|
Other: High Potassium/High Sodium Diet
Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the high potassium/high sodium diet.
|
7 days of the prescribed diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conduit artery endothelial-dependent dilation
Time Frame: on the 7th day of each diet
|
The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD
|
on the 7th day of each diet
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial Stiffness
Time Frame: on 7th day of each diet
|
Assessed by carotid to femoral artery pulse wave velocity
|
on 7th day of each diet
|
|
Wave reflection
Time Frame: on 7th day of each diet
|
Assessed by augmentation index
|
on 7th day of each diet
|
|
Endothelial cell expression of oxidative stress marker
Time Frame: on the 7th day of each diet
|
Assessed in venous endothelial cells from participants.
|
on the 7th day of each diet
|
|
Ambulatory blood pressure
Time Frame: 7 days
|
Assessed by 24 hr ambulatory blood pressure monitoring.
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 25, 2013
Primary Completion (Actual)
September 22, 2019
Study Completion (Actual)
September 22, 2019
Study Registration Dates
First Submitted
August 25, 2017
First Submitted That Met QC Criteria
August 25, 2017
First Posted (Actual)
August 29, 2017
Study Record Updates
Last Update Posted (Actual)
November 5, 2020
Last Update Submitted That Met QC Criteria
November 4, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 487998-8
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityCase Western Reserve University; Shirley Ryan AbilityLab; Skokie Health Department and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
Baylor College of MedicineNational Institutes of Health (NIH)CompletedCardiovascular Risk FactorUnited States
Clinical Trials on Moderate Potassium/Low Sodium Diet
-
University of DelawareNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Risk FactorUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of AlbertaCanadian Institutes of Health Research (CIHR)Not yet recruiting
-
Zhejiang UniversityNational Natural Science Foundation of China; Chinese PLA General Hospital; National...Completed
-
Brigham and Women's HospitalBoston Children's Hospital; Boston Medical Center; Nutrition Science Initiative; New Balance Foundation and other collaboratorsCompleted
-
Burke Rehabilitation HospitalCompletedStroke | Ischemic StrokeUnited States
-
Laval UniversityNot yet recruiting
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension | Obesity
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension